Molecular Characterization of Interleukin 2 Produced from Tumor Cell Lines and T Cell Hybridomas

  • S. Gillis
  • D. Mochizuki
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 100)

Abstract

As a laboratory which has been keenly interested in the molecular characterization and mechanism of action of T-cell growth factor (now referred to as Interleukin 2, IL-2) we initially turned to malignant cell lines and T-cell hybridomas as sources of crude conditioned medium from which to purify IL-2. Our hope from such an approach was to uncover cellular sources of IL-2 which would generate a higher titer conditioned medium than could be obtained by conventional protocols involving mitogen stimulation of either splenocytes or peripheral blood leukocytes. We chose to investigate IL-2 production both in cases in which putative producer cells were tested for constitutive lymphokine production and in cultures containing mitogens (PHA, Con-A, pokeweed, lipopolysaccharide) and/or phorbol esters. Because other investigators had previously shown that some murine lymphomas produced lymphokines only after lectin-triggering (I); we felt that a search solely for constitutive IL-2 producer cells might be too limited in terms of its chances for success. Abstracted below are the results of our initial studies together with experimental evidence detailing our recent progress on the biochemical characterization of IL-2. Such characterization has been further enhanced by our development of another hybridoma (of B-cell origin) whose monoclonal immunoglobulin reacts with a determinant present on the IL-2 molecule.

Keywords

Cellulose Lymphoma Leukemia Rubber Fractionation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ralph P, Broxmeyer M, Moore AS (1978) Induction of myeloid colony-stimulating activity in murine monocyte tumor cell lines by macrophage activators and in a T-cell line by concanavalin A. Cancer Res 38: 1414PubMedGoogle Scholar
  2. 2.
    Gillis S, Ferm MM, Ou W, Smith KA (1978) T cell growth factor: parameters of production and a quantitiative microassay for activity. J Immunol 120: 2027PubMedGoogle Scholar
  3. 3.
    Gillis S, Scheid M, Watson J (1980) Biochemical and biological characterization of lymhocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin 2 producing T cell lymphomas. J Immunol 125: 2570PubMedGoogle Scholar
  4. 4.
    Gillis S, Watson J (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an Inter leukin 2 producer human leukemia T cell line. J Exp Med 152: 1709PubMedCrossRefGoogle Scholar
  5. 5.
    Mochizuki DY, Watson J, Gillis S (1980) Biochemical separation of lnterleukin-2. J Immunol Methods 39: 185PubMedCrossRefGoogle Scholar
  6. 6.
    Frank MB, Watson JD, Gillis S (1981) Biochemical and biological characterization of lymphocyte regulatory molecules. VIII. Purification of Interleukin 2 from a human T- cell leukemia. J Immunol 127: 2361PubMedGoogle Scholar
  7. 7.
    Stull D, Gillis S (1981) Constitutive production of Interleukin 2 activity by a T cell hybridoma. J Immunol 126: 1680PubMedGoogle Scholar
  8. 8.
    Wiley HS, Wallace RA (1981) The structure of vitellogenin. Multiple vitellogenins in Xenopus laevis give rise to multiple forms of the yolk proteins. J Biol Chem in pressGoogle Scholar
  9. 9.
    Gillis S, Henney CS (1981) Biochemical and biological characterization of lymphocyte regulatory molecules. VI. Generation of a B cell hybridoma whose antibody product inhibits Interleukin 2 activity. J Immunol 126: 1978PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • S. Gillis
  • D. Mochizuki

There are no affiliations available

Personalised recommendations